4.6 Review

Comparative efficacy and acceptability of psychotherapies, pharmacotherapies, and their combination for the treatment of adult insomnia: A systematic review and network meta-analysis

期刊

SLEEP MEDICINE REVIEWS
卷 65, 期 -, 页码 -

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.smrv.2022.101687

关键词

Cognitive behavior therapy; Cognitive therapy; Behavior therapy; Psychotherapy; Pharmacotherapy; Insomnia

资金

  1. Ministry of Science and Tech- nology of the People's Republic of China [2021ZD0201900]
  2. National Natural Science Foundation of China [82120108002, 82170099, 82170100]

向作者/读者索取更多资源

This study compares the efficacy and acceptability of psychotherapies, pharmaco-therapies, and their combinations for treating insomnia. The results suggest that cognitive behavior therapy for insomnia (CBT-I) is more beneficial in improving subjective sleep efficiency compared to pharmacotherapy. However, pharmacotherapy may be more effective in improving certain sleep parameters. Combining CBT-I with pharmacotherapy appears to be more effective in improving sleep parameters compared to pharmacotherapy alone.
This study aims to explore the comparative efficacy and acceptability of psychotherapies, pharmaco-therapies, and their combinations for insomnia. MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, PsycINFO, CINAHL, and ClinicalTrials.gov were searched for randomized clinical trials (RCTs) examining the comparative efficacy in which a psychotherapy and a pharmacotherapy for insomnia were directly compared with each other, or in which a combination of psychotherapy and pharmacotherapy was compared with either alone. The analysis included data from 23 RCTs. In 18 of 23 studies, cognitive behavior therapy for insomnia (CBT-I) was the psychotherapy. At post-treatment, CBT-I showed higher subjective sleep efficiency (SE), and lower subjective wake time after sleep onset (WASO) and insomnia severity index (ISI) score. Compared with CBT-I plus pharmacotherapy, pharmacotherapy showed lower subjective SE, and higher subjective sleep latency (SL), PSG measured SL, subjective WASO, and ISI score. Overall, the findings derived from post-treatment data suggested that CBT-I is more beneficial in treating insomnia compared with pharmacotherapy. CBT-I combined with pharmacotherapy is beneficial in improving some sleep parameters (i.e., subjective SE, SL, WASO, and PSG measured SL) compared with pharmacotherapy alone. Daily clinical decisions should consider these findings on the relative efficacy of the principal approaches to insomnia treatment. (c) 2022 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据